Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Monday, April 19, 2010
FT.com / Elan reviews splitting into two groups
Elan Corporation, the Ireland-based drugmaker, may split into two separate businesses, after announcing it would explore the possibility of creating separately listed neurology and drug technology groups.
No comments:
Post a Comment